ProMIS Neurosciences shareholders approve 2025 stock plan and reelect directors

ProMIS Neurosciences Inc.

Shareholders approved 2025 Stock Option and Incentive Plan: 8,124,425 for, 828,874 against, 1,143,067 abstain.
All seven director nominees elected, including CEO Neil Warma, with no major withhold votes.
Ratification of Baker Tilly US, LLP as auditor for fiscal 2025 passed with 16,908,296 votes for.
New plan replaces 2015 Plan, authorizes 2,946,719 initial shares plus annual 5% of outstanding shares on Jan 1 each year.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.